H J Leach1, J A Devonish2, D G Bebb3, K A Krenz4, S N Culos-Reed5,6,7. 1. Faculty of Kinesiology, University of Calgary, Calgary, AB, Canada. hleach@ucalgary.ca. 2. Medical University of the Americas, Calgary, AB, Canada. jdevonish.phd@gmail.com. 3. Department of Oncology, Faculty of Medicine, University of Calgary, Calgary, AB, Canada. Gwyn.Bebb@albertahealthservices.ca. 4. Faculty of Kinesiology, University of Calgary, Calgary, AB, Canada. kakrenz@ucalgary.ca. 5. Faculty of Kinesiology, University of Calgary, Calgary, AB, Canada. nculosre@ucalgary.ca. 6. Department of Oncology, Faculty of Medicine, University of Calgary, Calgary, AB, Canada. nculosre@ucalgary.ca. 7. Department of Psychosocial Resources, Tom Baker Cancer Centre, Alberta Health Services, Calgary, AB, Canada. nculosre@ucalgary.ca.
Abstract
PURPOSE: Lung cancer poses multiple challenges to adopting an exercise (EX) program, and the ideal timing of an EX program to improve quality of life (QoL) is unknown. This study explored the EX counselling and programming preferences of lung cancer survivors and examined the association of EX before diagnosis, during treatment and after treatment on QoL. METHODS: Cross-sectional, retrospective survey design in a sample of lung cancer survivors. EX preferences were compared between patients who had received radical chest radiation or lung surgery versus those who had not. EX was measured by self-report using the Godin Leisure Time Exercise Questionnaire (GLTEQ). Separate linear regression models, controlling for significant covariates, examined the association of EX at each time point with scores on QoL measures and subscales. RESULTS: Participants (N = 66, M age 66.4 ± 9.1) were between 4 months and 11.5 years after lung cancer diagnosis (M = 31.7 ± 22.9 months). Patients who had lung surgery were more likely to prefer to start an EX program during adjuvant treatment than those who did not have surgery (t(33) = 2.43, p = .025). Compared to prediagnosis EX (M = 36.7 ± 56.0 MET h/week), EX levels declined significantly during (M = 12.4 ± 25.0 MET h/week) and after (M = 12.3 ± 17.4 MET h/week) treatment (p < .05). After controlling for disease stage and income, regression models were not significant, but EX after treatment was a significant individual predictor of fatigue (β = .049, p = .006) and QoL measured by the Chronic Respiratory Disease Questionnaire (β = .163, p = .025). CONCLUSIONS: Lung cancer patient preferences indicate that EX program timing should take into account whether the patient has undergone surgery. Lung cancer survivors' EX levels declined after diagnosis and engaging in EX after treatment may improve fatigue and QoL.
PURPOSE:Lung cancer poses multiple challenges to adopting an exercise (EX) program, and the ideal timing of an EX program to improve quality of life (QoL) is unknown. This study explored the EX counselling and programming preferences of lung cancer survivors and examined the association of EX before diagnosis, during treatment and after treatment on QoL. METHODS: Cross-sectional, retrospective survey design in a sample of lung cancer survivors. EX preferences were compared between patients who had received radical chest radiation or lung surgery versus those who had not. EX was measured by self-report using the Godin Leisure Time Exercise Questionnaire (GLTEQ). Separate linear regression models, controlling for significant covariates, examined the association of EX at each time point with scores on QoL measures and subscales. RESULTS:Participants (N = 66, M age 66.4 ± 9.1) were between 4 months and 11.5 years after lung cancer diagnosis (M = 31.7 ± 22.9 months). Patients who had lung surgery were more likely to prefer to start an EX program during adjuvant treatment than those who did not have surgery (t(33) = 2.43, p = .025). Compared to prediagnosis EX (M = 36.7 ± 56.0 MET h/week), EX levels declined significantly during (M = 12.4 ± 25.0 MET h/week) and after (M = 12.3 ± 17.4 MET h/week) treatment (p < .05). After controlling for disease stage and income, regression models were not significant, but EX after treatment was a significant individual predictor of fatigue (β = .049, p = .006) and QoL measured by the Chronic Respiratory Disease Questionnaire (β = .163, p = .025). CONCLUSIONS:Lung cancerpatient preferences indicate that EX program timing should take into account whether the patient has undergone surgery. Lung cancer survivors' EX levels declined after diagnosis and engaging in EX after treatment may improve fatigue and QoL.
Entities:
Keywords:
Exercise preference; Lung cancer; Physical activity; Quality of life
Authors: Morten Quist; Mikael Rørth; Seppo Langer; Lee W Jones; Jørgen H Laursen; Helle Pappot; Karl Bang Christensen; Lis Adamsen Journal: Lung Cancer Date: 2011-08-03 Impact factor: 5.705
Authors: Jos A Stigt; Steven M Uil; Susanne J H van Riesen; Frans J N A Simons; Monique Denekamp; Ghada M Shahin; Harry J M Groen Journal: J Thorac Oncol Date: 2013-02 Impact factor: 15.609
Authors: Elliot J Coups; Bernard J Park; Marc B Feinstein; Richard M Steingart; Brian L Egleston; Donna J Wilson; Jamie S Ostroff Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-02-03 Impact factor: 4.254
Authors: Catherine L Granger; Bronwen Connolly; Linda Denehy; Nicholas Hart; Phillip Antippa; Kuan-Yin Lin; Selina M Parry Journal: Support Care Cancer Date: 2016-11-29 Impact factor: 3.603
Authors: Duc M Ha; Allan V Prochazka; David B Bekelman; Jennifer E Stevens-Lapsley; Edward D Chan; Robert L Keith Journal: JNCI Cancer Spectr Date: 2021-01-23
Authors: Melissa J J Voorn; Bart C Bongers; Vivian E M van Kampen-van den Boogaart; Elisabeth J M Driessen; Maryska L G Janssen-Heijnen Journal: Cancers (Basel) Date: 2022-05-12 Impact factor: 6.575
Authors: Lara Edbrooke; Linda Denehy; Catherine L Granger; Suzanne Kapp; Sanchia Aranda Journal: Support Care Cancer Date: 2019-04-13 Impact factor: 3.603
Authors: Brett C Bade; Mary C Brooks; Sloan B Nietert; Ansley Ulmer; D David Thomas; Paul J Nietert; JoAnn B Scott; Gerard A Silvestri Journal: Integr Cancer Ther Date: 2016-12-27 Impact factor: 3.279